Ugmad, Bb Boy .

HRN: 28-79-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
AMPICILLIN 250MG (VIAL)
04/04/2026
04/10/2026
IV
110mg
Q12
RDS
Remove - Pending Acceptance
04/04/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
04/04/2026
04/10/2026
IV
11mg
Q24
RDS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: